Good levels to buy TRVN

NASDAQ:TRVN   Trevena, Inc
Very bullish for NASDAQ:TRVN in the long term.
- High demand product with blockbuster drug good for opiod crisis.
- Potential replacement for morphine, no real competitor
- Partnership with Syneos for sales
- Potential buyout

Good levels to buy at 2.50 and 2.33

Should see rise towards next quarter earnings .

Long term PTs
TP1 - $5
TP2 - $15
TP3 - $30
Comment: hold
Falling wedge pattern in the short term and an ascending triangle on the mid term.

Continue hold towards next quarter earnings in March
Comment: Seems to breaking out of the falling wedge